Terms: = Leukemia AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Clinical Outcome
1 results:
1. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
[TBL] [Abstract] [Full Text] [Related]
